14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $20.84 $26.05 Thursday, 25th Apr 2024 CORT stock ended at $22.21. This is 1.20% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 3.32% from a day low at $22.00 to a day high of $22.73.
90 days $20.84 $26.05
52 weeks $20.84 $34.28

Historical Corcept Therapeutics Incorporated prices

Date Open High Low Close Volume
Jan 08, 2024 $26.00 $27.54 $25.19 $27.46 1 741 509
Jan 05, 2024 $25.00 $25.03 $24.05 $24.28 1 190 669
Jan 04, 2024 $25.59 $25.59 $24.86 $25.34 1 272 816
Jan 03, 2024 $24.35 $25.81 $24.11 $25.39 2 513 130
Jan 02, 2024 $22.11 $25.73 $22.00 $24.16 7 371 857
Dec 29, 2023 $32.87 $33.07 $32.43 $32.48 561 183
Dec 28, 2023 $32.97 $33.25 $32.83 $32.88 482 325
Dec 27, 2023 $32.64 $33.13 $32.48 $32.82 871 420
Dec 26, 2023 $32.78 $33.19 $32.06 $32.42 454 060
Dec 22, 2023 $31.75 $32.84 $31.70 $32.76 797 411
Dec 21, 2023 $31.17 $31.75 $30.72 $31.66 587 551
Dec 20, 2023 $31.50 $31.79 $30.86 $30.88 488 342
Dec 19, 2023 $30.71 $31.45 $30.66 $31.23 842 284
Dec 18, 2023 $29.98 $30.64 $29.71 $30.54 750 288
Dec 15, 2023 $29.98 $30.23 $29.66 $29.75 1 363 913
Dec 14, 2023 $30.12 $30.32 $29.76 $29.83 615 575
Dec 13, 2023 $28.19 $30.74 $28.13 $30.07 1 591 847
Dec 12, 2023 $27.32 $27.92 $26.93 $27.85 363 274
Dec 11, 2023 $26.74 $27.24 $26.32 $27.19 441 570
Dec 08, 2023 $26.74 $26.98 $26.46 $26.54 345 712
Dec 07, 2023 $26.92 $27.10 $26.30 $26.73 490 131
Dec 06, 2023 $26.39 $27.13 $26.29 $27.04 367 839
Dec 05, 2023 $26.14 $26.77 $26.06 $26.46 510 996
Dec 04, 2023 $26.00 $26.38 $25.84 $26.26 424 210
Dec 01, 2023 $25.47 $26.00 $25.27 $25.97 559 099
Click to get the best stock tips daily for free!

About Corcept Therapeutics Incorporated

Corcept Therapeuticsorporated Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have ... CORT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT